Novartis buys Chinook for US$3.2-billion, latest in string of big exits for Canadian biotechs
Swiss drug giant will pay US$40 a share for Chinook; shareholders could receive an additional US$4 a share if further milestones are reached
Stay updated with breaking news from Nicolas Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Swiss drug giant will pay US$40 a share for Chinook; shareholders could receive an additional US$4 a share if further milestones are reached
The market is seeing a supportive environment for munis, said Nisha Patel, managing director of SMA Portfolio Management at Parametric.
"With rates volatility seemingly subsiding in the past few weeks, we could start to see outflows decrease and demand flow back into munis," according to AmeriVet Securities' Jason Wong.
Investors will be greeted Monday with a new-issue calendar estimated at $6.018 billion with a few bellwether, triple-A names coming from Loudoun County, Virginia, Frederick County, Maryland, and Columbia University with sizable deals.